目的分析甲型H1N1流感病毒的基因组序列特征,阐明该毒株的遗传变异及分子特性。方法GenBank中获取流感病毒全序列,对各段基因与已知序列进行分析比较,绘制进化树,并分析和预测甲型毒株的致病性、药物敏感性和现有疫苗的预防保护作用。结果甲型H1N1病毒的HA、PB2、PB1、PA、NP、NS基因与美国本土的猪流感病毒序列具有高度同源性,NA和M基因具有典型的欧亚株系猪流感病毒特征。该病毒具有人传人的分子基础,HA上HAl和HA2裂解位点序列为PSIQSR↓GLFGAI,尚不具备高致病性流感病毒的特征。病毒对金刚烷胺类药物耐药,而对达菲和扎那米韦敏感。HA片段5个抗原决定区氨基酸序列与人用流感疫苗具有较大差异,推测现有疫苗对预防本次疫情基本无效。结论甲型HIN1是一种北美和欧亚两种猪流感病毒的混合体,开发针对本病毒的流感疫苗有助于进一步控制疫情蔓延。
Objective To analyse the genome of influeriza A(H1N1) vires so as to elucidate its molecular characteristics and evolution status. Methods DNA sequences of the influenza viruses were collected from NCBI, and compared with the genomes of referenced influenza viruses. The phylogenetic trees were constructed by the neighbor-joining method, and the pathogenicity, drug susceptibility and vaccine protection were analyzed. Results Phylogenetic analysis showed that the genes encoding HA, PB2, PB1, PA, NP, and NS protein were most closely related to those influenza A viruses circulating in swine populations in North America. NA and M gene belonged to Eurasia lineages swine influenza virus. The amino acid sequence of the cleavage site between HA1 and HA2 was PARSSR ↓ GLFGAI with the typical characteristics of the low pathogenic influenza virus. Influenza A (H1N1) virus can spread from person-to-person. It is sensitive to osehamivir and zanamivir but resistant to amantadine and remantadine. The current human seasonal influenza vaccines confered little protection against influenza A/H1N1 because of the great diversity on antigenic domains between A/H1N1 virus and vaccine virus. Condusions Influenza A(H1N1) virus is a reassortant virus of North America and Eurasia lineages swine influenza virus. It is important to develop a vaccine against the currently circulating virus strain to control the disease spread.